Literature DB >> 23064038

Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children.

E Charrier1, P Cordeiro, R-M Brito, S Mezziani, S Herblot, F Le Deist, M Duval.   

Abstract

Some clinical characteristics of cord blood transplantation (CBT) might be explained by specificities in the reconstitution of immune subsets differing by their maturation stage or their implication in GVHD, tolerance or immune responses against tumor or infectious agents. Here, we compare the immune reconstitution of several of these subsets after CBT and BMT. B-cell count recovery was faster after CBT. There was no difference in the recovery of CD4(+) and CD8(+) cell counts. There was no difference either in the frequency of several subsets: CD45RO(+) memory, and CD45RA(+) naïve cells within the CD4(+) T-cell compartment, CD27(+) among B cells, CD56(bright), NKG2A(+), and KIR(+) cells among natural killer (NK) cells, CD25(+)FOXP3(+) regulatory T cells and invariant NKT cells. The proportion of the thymic naïve CD31(+)CD45RA(+)CD4(+) T cells was lower after CBT at 6 months post-transplant, and was still below normal at 1 year in both groups. NK-cell expansion was more sustained after CBT, with fewer double-negative NKG2A(-)KIR(-) hyporesponsive cells and more double-positive NKG2A(+)KIR(+) hyper-responsive NK cells. These results, therefore, indicate that further research to improve CBT outcome should try to improve thymopoieisis and take advantage of the sustained NK-cell reconstitution.

Entities:  

Mesh:

Year:  2012        PMID: 23064038     DOI: 10.1038/bmt.2012.176

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  13 in total

Review 1.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

2.  Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.

Authors:  A Xhaard; H Moins-Teisserenc; M Busson; M Robin; P Ribaud; N Dhedin; S Abbes; M Carmagnat; V-D Kheav; G Maki; R Peffault de Latour; A Toubert; G Socié
Journal:  Bone Marrow Transplant       Date:  2014-05-19       Impact factor: 5.483

3.  Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Authors:  Rachel J Bergerson; Robin Williams; Hongbo Wang; Ryan Shanley; Gretchen Colbenson; Alyssa Kerber; Sarah Cooley; Julie Curtsinger; Martin Felices; Jeffrey S Miller; Michael R Verneris
Journal:  Blood Adv       Date:  2016-10-30

4.  Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency.

Authors:  Holly K Miller; Patrick J Hanley; Haili Lang; Christopher A Lazarski; Elizabeth A Chorvinsky; Sarah McCormack; Lauren Roesch; Shuroug Albihani; Marcus Dean; Fahmida Hoq; Roberta H Adams; Catherine M Bollard; Michael D Keller
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-09       Impact factor: 5.742

5.  Neutrophil function in children following allogeneic hematopoietic stem cell transplant.

Authors:  Michael W Kent; Marguerite R Kelher; Christopher C Silliman; Ralph Quinones
Journal:  Pediatr Transplant       Date:  2016-04-25

Review 6.  Immune function in childhood cancer survivors: a Children's Oncology Group review.

Authors:  Gregory M T Guilcher; Linda Rivard; Jennifer T Huang; Nicola A M Wright; Lynette Anderson; Hesham Eissa; Wendy Pelletier; Shanti Ramachandran; Tal Schechter; Ami J Shah; Ken Wong; Eric J Chow
Journal:  Lancet Child Adolesc Health       Date:  2021-02-16

Review 7.  Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.

Authors:  Charlotte I S Barker; Eva Germovsek; Rollo L Hoare; Jodi M Lestner; Joanna Lewis; Joseph F Standing
Journal:  Adv Drug Deliv Rev       Date:  2014-01-17       Impact factor: 15.470

8.  Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation.

Authors:  Evelyn Ullrich; Emilia Salzmann-Manrique; Shahrzad Bakhtiar; Melanie Bremm; Stephanie Gerstner; Eva Herrmann; Peter Bader; Petra Hoffmann; Ernst Holler; Matthias Edinger; Daniel Wolff
Journal:  Front Immunol       Date:  2016-12-22       Impact factor: 7.561

9.  Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.

Authors:  Xiaohua Chen; Memphis Hill; Mark Vander Lugt; Maria Escolar; Zhou Fang; Wei Chen; Paul Szabolcs
Journal:  Cytotherapy       Date:  2020-02-21       Impact factor: 6.196

10.  TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.

Authors:  Martin Lelaidier; Yildian Dìaz-Rodriguez; Martine Cordeau; Paulo Cordeiro; Elie Haddad; Sabine Herblot; Michel Duval
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.